Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 901–915 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-554
Serum Carotene (Beta‑Carotene) Test

This test measures serum beta-carotene levels to assess vitamin A status and antioxidant capacity.

Serum 2–3 weeks after sample batch (monthly processing) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Beta-Carotene Concentration", "Provitamin A Levels"]
Parameters
[{"name": "Serum Beta-Carotene", "reference_range": null}]
Preparation
["Fast overnight for 12 hours", "Avoid alcohol for 24 hours", "Avoid vitamin A supplements for 24 hours", "Protect sample from light"]
Indications
["Assessment of vitamin A status", "Evaluation of antioxidant reserves", "Risk assessment for age-related macular degeneration", "Monitoring nutritional status"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2305-7 ICD-10: E50.9, E64.2
Clinical summary
This test measures serum beta-carotene levels to assess vitamin A status and antioxidant capacity.
TEST-2822
Serum Oxalate Test

This diagnostic test evaluates the concentration of oxalate in the blood serum.

Serum 2–3 weeks 1,300.00 AED
View
View test specifications and preparation
What it measures
["Serum Oxalate Concentration"]
Parameters
[{"name": "Serum Oxalate", "reference_range": null}]
Preparation
["Avoid vitamin C supplements for 48 hours before collection", "Avoid vitamin-C-rich foods (citrus fruits, strawberries, bell peppers) for 48 hours before collection"]
Indications
["Diagnosis of primary hyperoxaluria", "Evaluation of recurrent kidney stones", "Monitoring renal function in specific conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 1987-9 ICD-10: E72.53, N20.0
Clinical summary
This diagnostic test evaluates the concentration of oxalate in the blood serum.
TEST-2984
Serum Protein Electrophoresis & Immunotyping Test

This diagnostic test evaluates the types and quantities of proteins in the blood serum, specifically looking for abnormal monoclonal proteins.

Serum Next working day (sample by 9 AM) 1,500.00 AED
View
View test specifications and preparation
What it measures
["Serum protein fractions (albumin, alpha-1, alpha-2, beta, gamma)", "Monoclonal immunoglobulins (heavy and light chain types)"]
Parameters
[{"name": "Serum Protein Electrophoresis", "reference_range": "Albumin: 3.5-5.0 g/dL, Alpha-1: 0.1-0.3 g/dL, Alpha-2: 0.6-1.0 g/dL, Beta: 0.7-1.1 g/dL, Gamma: 0.7-1.6 g/dL (Ranges may vary slightly)"}, {"name": "Immunofixation Electrophoresis", "reference_range": "No monoclonal protein detected"}]
Preparation
["No special preparation required", "Fasting is not necessary"]
Indications
["Suspected multiple myeloma", "Evaluation of monoclonal gammopathy of undetermined significance (MGUS)", "Diagnosis of amyloidosis", "Investigation of recurrent infections", "Monitoring response to treatment for plasma cell disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49380-1 ICD-10: C90.0
Clinical summary
This diagnostic test evaluates the types and quantities of proteins in the blood serum, specifically looking for abnormal monoclonal proteins.
TEST-4924
SETD5 Gene Genetic Test for Autosomal Dominant Intellectual Disability Type 23 (MRD23)

This test detects pathogenic variants in the SETD5 gene associated with autosomal dominant intellectual disability type 23 (MRD23).

Whole Blood (3 mL) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SETD5 gene"]
Parameters
[]
Preparation
["Genetic counseling is mandatory before testing.", "Informed consent must be obtained.", "Minors require parental or guardian consent."]
Indications
["Suspected autosomal dominant intellectual disability type 23 (MRD23)", "Family history of intellectual disability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: F79, Z14.8, Z13.79
Clinical summary
This test detects pathogenic variants in the SETD5 gene associated with autosomal dominant intellectual disability type 23 (MRD23).
TEST-5864
SFTPB Gene Surfactant Metabolism Dysfunction Type 1 Genetic Test

This test evaluates the SFTPB gene for pathogenic variants associated with surfactant metabolism dysfunction type 1.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SFTPB gene", "Surfactant metabolism dysfunction type 1"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory.", "A detailed family pedigree is required."]
Indications
["Infants with unexplained respiratory distress", "Family history of the disease", "Carrier screening in at-risk families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93239-9 ICD-10: P27.0
Clinical summary
This test evaluates the SFTPB gene for pathogenic variants associated with surfactant metabolism dysfunction type 1.
TEST-4726
SGCA Gene Limb‑Girdle Muscular Dystrophy Type 2D Genetic Test

This genetic test identifies pathogenic variants in the SGCA gene associated with Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D).

Peripheral Whole Blood (EDTA) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SGCA gene", "SNVs, indels, and copy number changes"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications being taken"]
Indications
["Suspected diagnosis of Limb-Girdle Muscular Dystrophy Type 2D", "Family history of LGMD2D", "Carrier screening in at-risk individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95983-4 ICD-10: G71.0, Z14.8, Z13.79
Clinical summary
This genetic test identifies pathogenic variants in the SGCA gene associated with Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D).
TEST-5995
SGSH Gene Mucopolysaccharidosis Type IIIA (Sanfilippo A Syndrome) Genetic Test

This test identifies pathogenic variants in the SGSH gene, confirming a diagnosis of Mucopolysaccharidosis Type IIIA (Sanfilippo A Syndrome) or determining carrier status.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SGSH gene", "Presence of missense, nonsense, splice-site, indel, and copy-number variants"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session.", "Completion of informed consent documentation.", "Provision of complete clinical history from referring physician."]
Indications
["Diagnosis of suspected Mucopolysaccharidosis Type IIIA (Sanfilippo A Syndrome)", "Carrier screening for at-risk family members", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21631-1 ICD-10: E76.22
Clinical summary
This test identifies pathogenic variants in the SGSH gene, confirming a diagnosis of Mucopolysaccharidosis Type IIIA (Sanfilippo A Syndrome) or determining carrier status.
TEST-5873
SI Gene Sucrase-Isomaltase Deficiency Genetic Test

This test evaluates the SI gene for pathogenic variants associated with congenital sucrase-isomaltase deficiency (CSID).

Peripheral Whole Blood or FTA Card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SI gene", "Genetic mutations affecting sucrase-isomaltase enzyme production"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Suspected congenital sucrase-isomaltase deficiency (CSID)", "Chronic diarrhoea unresponsive to standard treatment", "Family history of CSID"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81319-8 ICD-10: E74.31
Clinical summary
This test evaluates the SI gene for pathogenic variants associated with congenital sucrase-isomaltase deficiency (CSID).
TEST-3800
SIGMAR1 Gene ALS Type 16 Genetic Test

This test identifies pathogenic variants within the SIGMAR1 gene associated with Amyotrophic Lateral Sclerosis Type 16 (ALS16).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SIGMAR1 gene", "Presence of mutations linked to ALS16"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected diagnosis of ALS type 16", "Family history of ALS16", "Genetic risk assessment for ALS16"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94436-0 ICD-10: G12.21
Clinical summary
This test identifies pathogenic variants within the SIGMAR1 gene associated with Amyotrophic Lateral Sclerosis Type 16 (ALS16).
TEST-3119
Silver Serum Test

This diagnostic test evaluates the concentration of silver in the blood serum.

Serum 2 business days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Total silver concentration", "Systemic silver absorption"]
Parameters
[{"name": "Silver", "reference_range": null}]
Preparation
["Do not discontinue prescribed medication without consulting your doctor.", "Avoid all silver-containing medications, dietary supplements, and colloidal silver products for at least 3 days prior to collection.", "If Gadolinium or Iodine contrast media was administered, wait 96 hours before specimen collection.", "Use only powder-free gloves during collection.", "Serum must be obtained from a metal-free White Top tube (Z tube, no additive)."]
Indications
["Monitoring industrial exposure", "Potential silver toxicity (argyria/argyrosis)", "Anti-aging therapy safety", "Occupational exposure", "Colloidal silver use"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77274-0 ICD-10: T56.891X1A, Z77.018, Z15.09
Clinical summary
This diagnostic test evaluates the concentration of silver in the blood serum.
TEST-3134
Sirolimus (Rapamycin) Test

This test measures the concentration of sirolimus (rapamycin) in whole blood to guide immunosuppressive therapy.

Whole Blood (EDTA) Same-day reporting when sample arrives by 5 PM 900.00 AED
View
View test specifications and preparation
What it measures
["Sirolimus (Rapamycin) concentration", "Therapeutic drug level"]
Parameters
[{"name": "Sirolimus (Rapamycin) Trough Level", "reference_range": null}]
Preparation
["Fasting is not required.", "Maintain usual medication schedule.", "Avoid taking morning dose until after blood draw.", "Sample must be drawn immediately before next scheduled dose."]
Indications
["Solid organ transplant recipients (kidney, liver, etc.)", "Monitoring therapeutic drug levels", "Dose adjustment guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3395-0 ICD-10: Z51.81
Clinical summary
This test measures the concentration of sirolimus (rapamycin) in whole blood to guide immunosuppressive therapy.
TEST-3922
SLC12A1 Gene (Bartter Syndrome Type 1) Next-Generation Sequencing (NGS) Genetic Test

This test evaluates the SLC12A1 gene for pathogenic variants associated with Bartter syndrome type 1.

Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) 3 to 4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC12A1 gene", "Copy number alterations in the SLC12A1 gene"]
Parameters
[]
Preparation
["No fasting required", "Genetic counselling session mandatory prior to collection"]
Indications
["Suspected Bartter syndrome type 1", "Family history of Bartter syndrome type 1", "Recurrent unexplained hypokalemia", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21634-2 ICD-10: E26.81
Clinical summary
This test evaluates the SLC12A1 gene for pathogenic variants associated with Bartter syndrome type 1.
TEST-3933
SLC12A2 Gene Next-Generation Sequencing (Genetic Test for Bartter Syndrome

This test analyzes the entire SLC12A2 gene to detect pathogenic variants associated with Bartter syndrome type 1.

Whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC12A2 gene", "Na-K-2Cl cotransporter (NKCC1) function"]
Parameters
[]
Preparation
["Complete a formal genetic counselling session", "Provide a detailed three-generation family pedigree", "Maintain normal hydration", "No fasting required"]
Indications
["Suspected Bartter syndrome type 1 based on clinical presentation", "Family history of Bartter syndrome", "Carrier screening for family members", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94220-2 ICD-10: E26.81
Clinical summary
This test analyzes the entire SLC12A2 gene to detect pathogenic variants associated with Bartter syndrome type 1.
TEST-3878
SLC12A7 Gene Bartter Syndrome Genetic Test

This test evaluates the SLC12A7 gene for pathogenic variants associated with Bartter syndrome.

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in SLC12A7 gene", "Copy Number Variants (CNVs) in SLC12A7 gene"]
Parameters
[]
Preparation
["Do not discontinue prescribed medications without consulting your physician"]
Indications
["Clinical diagnosis of Bartter syndrome", "Carrier screening", "Family risk stratification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21674-2 ICD-10: E26.81, R79.8
Clinical summary
This test evaluates the SLC12A7 gene for pathogenic variants associated with Bartter syndrome.
TEST-6355
SLC16A1 Gene Erythrocyte Lactate Transporter Defect Genetic Test

This genetic test identifies pathogenic variants in the SLC16A1 gene, which encodes the erythrocyte lactate transporter MCT1.

Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLC16A1 gene sequence", "Pathogenic variants in SLC16A1"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without physician instruction", "Inform phlebotomist if on anticoagulant therapy"]
Indications
["Unexplained exercise intolerance", "Hyperlactatemia", "Suspected metabolic disorder related to lactate transport"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92834-7 ICD-10: E74.81
Clinical summary
This genetic test identifies pathogenic variants in the SLC16A1 gene, which encodes the erythrocyte lactate transporter MCT1.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area